Phototheranostic Nanoagents for Imaging‐Guided Treatment of Oral Cancer^†

Abstract

Comprehensive Summary Phototherapy showed almost a lack of drug resistance and, depending on the therapeutic effects of non‐invasive light‐stimulating photosensors. The side effects of phototherapy were greatly reduced compared to their traditional equivalents. Phototheranostic nanoagents had new properties in drug delivery, biocompatibility, targeting and response, in which traditional phototheranostic drugs can not possess. Recently, a large number of relevant studies have demonstrated that photodynamic therapy (PDT) in combination with other agents and image‐guided multifunctional photothermal therapy (PTT) were well suited for the treatment of oral cancer. Through the design of the nanoagents, researchers have discovered various applications for phototherapy, such as targeted release of co‐packaged drugs, multifunctional imaging for diagnosis and treatment combination, accurate targeting caused by nanocarriers, and synergistic chemotherapy with phototherapy. In this paper, we first reviewed the research related to phototheranostic nanoagents for image‐guided treatment of oral cancer. We tried to introduce the design concept and the treatment effect by three parts of components of phototheranostic nanoagents, categories of phototheranostic nanoagents and application of phototheranostic nanoagents. It also provided a reference for nanomaterial development and clinical applications in research of oral cancer treatment.

Photothermally Enhanced Dual Enzyme‐mimic Activity of Gold‐Palladium Hybrid Nanozyme for Cancer Therapy

“…In particular, NIR‐controlled photothermal nanoplatforms can regulate enzyme activity in cancer cells, leading to enhanced anti‐tumor effects. [ 25‐26 ] Wang et al . [ 27 ] designed NIR light‐responsive nanozymes by modifying ultra‐small platinum nanoparticles (Pt NPs) into the interior of various enzymes, which achieved local thermal therapy through the excellent photothermal conversion effect of Pt NPs mediating, thereby enhancing the enzyme activity.…”

Stimuli-Responsive Hydrogels Potentiating Photothermal Therapy against Cancer Stem Cell–Induced Breast Cancer Metastasis

“…Based on the above considerations, an aggregation-induced emission luminogen (AIEgen) was synthesized and applied as a photothermal agent. It generates heat upon aggregation state after NIR laser exposure, enabling photothermal therapy (PTT) and serving as a trigger for a hydrogel-based drug release system. − However, the therapeutic outcome of PTT alone is still inadequate to interfere with the tenacious cellular activity of CSCs. ,,− Recent clinical research has shown that patients who received dopamine receptor (DR) antagonists showed a reduced incidence of cancer metastasis due to efficient inhibition of DR expression and CSC proliferation. ,− …”